CrushSCI.com
Journal Selection & Manuscript Polishing Services
Clinical Breast Cancer journal cover Medicine
Back to journal directory

Review Cycle Records

Clinical Breast Cancer

Elsevier SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q3
82.1Average days
75Median days
4Fastest days
296Longest days
2462025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

61 days

The Effect of Germline Pathogenic Variants in the Upgrade Rate to Breast Cancer Among Patients Diagnosed With Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Core Needle Biopsy

AuthorsKomal Ijaz; Broden Alston; Therese Bevers; Banu Arun; Diane Weber; Min Yi; Kelly Hunt; Gary Whitman; Lavinia P. Middleton

AffiliationsDepartments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Source PDF DOI Publisher page
4 days

Intraoperative and Perioperative Outcomes of Breast-Conserving Surgery After Neoadjuvant Systemic Therapy: A Retrospective Cohort Study

AuthorsYashasvini Sampathkumar; Rebecca Yu; Tiana Y. Sepahpour; Hanae K. Tokita; William E. Rosa; Anoushka Afonso; Andrew Vickers; Melissa Assel; Anita Mamtani; Jennifer R. Majumdar

AffiliationsDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY; Hunter-Bellevue School of Nursing, City University of New York, New York, NY

Source PDF DOI Publisher page
4 days

A Multicenter Retrospective Study on Screening Patients Eligible for Exemption From Axillary Surgery Based on the Pathological Remission of the Breast After Neoadjuvant Therapy

AuthorsXingye Sheng; Hong Yin; Xiaoqing Zhang; Lingjun Ma; Xinyu Wan; Wenxiang Shi; Mingyu Wang; Junhan Li; Danni Shen; Ying Zhu; Weifeng Qian; Jue Wang

AffiliationsDepartment of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Breast Surgery, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing, China; Department of Breast Disease, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China; Department of Gastrointestinal Surgery, Changzhou Medical Center, Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, The Third Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Changzhou, China; Department of Breast and Thyroid Surgery, Gusu School, The Affiliated Suzhou Hospital of Nanjing Medical University, Nanjing Medical University, Suzhou, China; Department of General Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China

Source PDF DOI Publisher page
90 days

The Impact of Expanded Access to Germline High Penetrance Genetic Testing for Women With a New Diagnosis of Invasive Breast Cancer or High-Grade DCIS

AuthorsSarah P. Hudson-Phillips; Akriti Nanda; Mohamed Attia; Wadha Al Yaqout; Evelyn Marshall; Jennifer E. Rusby; Katherine Krupa; Peter A. Barry; Marios Konstantinos Tasoulis; Gerald Gui; Radhika Merh; Bethany Torr; Zoe Kemp; Angela George; Clare Turnbull; Rachel L. O’Connell

AffiliationsDepartment of Breast Surgery, The Royal Marsden Hospital, London, UK; Department of General Surgery, Cairo University Hospitals, Cairo, Egypt; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Department of Breast Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK

Source PDF DOI Publisher page
99 days

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety

AuthorsClaudia von Arx; Alessandra Calabrese; Michela Piezzo; Vincenzo Di Lauro; Claudia Martinelli; Claudia Calderaio; Margherita Tafuro; Annarita Verrazzo; Raffaella Di Monda; Enrico Magri; Maria Luisa D’aulisio Garigliota; Anna Maria Di Filippo; Roberto Buonaiuto; Giuseppe Buono; Roberta Caputo; Daniela Cianniello; Ivana Cerillo; Stefania Cocco; Rossana Di Rienzo; Francesco Nuzzo; Carmen Pacilio; Martina Pagliuca; Sara Parola; Matilde Pensabene; Francesca Poggio; Carmine De Angelis; Lucia Del Mastro; Michelino De Laurentiis

AffiliationsDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS ``Fondazione G. Pascale'', Naples, Italy; Clinical and Translational Oncology, Scuola Superiore Meridionale (SSM), Naples, Italy; Université Paris-Saclay, Gustave Roussy, Inserm, Prédicteurs Moléculaires et Nouvelles Cibles En Oncologie, Villejuif, France; IRCSS Ospedale Policlinico San Martino, UO Clinica Oncologia Medica, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DIMI), Università di Genova, Genoa, Italy

Source PDF DOI Publisher page
8 days

Implementation of Targeted Axillary Dissection in Clinically Node-Positive Breast Cancer: Adoption Trends and Comparative Outcomes at a Single Institution

AuthorsSkylar Harbour; Michelle Ki; Connie Chen; Victoria Dai; Sheldon Feldman; Ethan Ravetch; Ruth Samson; Maureen McEvoy

AffiliationsAlbert Einstein College of Medicine, Bronx, NY; Department of Breast Surgery, Montefiore Medical center, Bronx, NY

Source PDF DOI Publisher page
53 days

Overall Survival After Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Patients With Three Recorded Positive Nodes: A National Cancer Database Analysis

AuthorsKai Huang; Emmanuel Gabriel

AffiliationsDepartment of Surgery, Prevea Health, St. Vincent Regional Cancer Center, Green Bay , WI; Department of Surgery, Mayo Clinic Florida, Jacksonville, FL

Source PDF DOI Publisher page
89 days

CTSG Suppresses Breast Cancer Progression by Inhibiting the EGFR/ERK Signaling Pathway and Enhancing CD8⁺ T Cell Activation

AuthorsYue Pan; Chenhui Zheng; Danni Zheng; Yin Pan

AffiliationsDepartment of Surgical Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China

Source PDF DOI Publisher page
296 days

Cost-effectiveness of Biennial Breast Screening in Women With Dense Breasts: Exploratory Analysis of Pathways Incorporating an Emerging Blood RNA Test

AuthorsJacie T. Cooper; Alan Hollingsworth; Randy D. Moore; Cheryl Croft; John Schneider; Kristina D. Rinker; Eldon Spackman

AffiliationsAvalon Health Economics, Miami, FL; Syantra Inc., Calgary, AB, Canada; Croft Healthcare Consulting LLC, Jacksonville, FL; Department of Biomedical Engineering and Department of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada; Department of Surgery, University of Calgary, Calgary, AB, Canada

Source PDF DOI Publisher page
117 days

Epigenetic Remodeling Through GSK343-induced EZH2 Inhibition Alters SMYD2/SMYD3 Expression and Promotes Antitumor Effects

AuthorsThaís Amanda Damasceno Silva; Eduardo Vignoto Fernandes; Mayara Bocchi; Fermino Sanches Lizarte Neto; Fábio Morato de Oliveira

AffiliationsLaboratory of Human and Medical Genetics, Federal University of Jataí, Jataí-GO, Brazil; Laboratory of Immunometabolism, Nutrition, and Exercise (LABINE), Federal University of Jataí, Jataí-GO, Brazil; Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.